United Capital Financial Advisers, LLC Sarepta Therapeutics, Inc. Transaction History

United Capital Financial Advisers, LLC

$19.9 Billion
Q3 2024

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 13, 2021	SELL	$69.38 - $86.75 $895,348 - $1.12 Million	-12,905 Closed	0 $0
Q1 2021 May 14, 2021	SELL	$72.25 - $168.95 $8,308 - $19,429	-115 Reduced 0.88%	12,905 $962,000
Q4 2020 Feb 17, 2021	BUY	$125.56 - $178.74 $111,622 - $158,899	889 Added 7.33%	13,020 $2.22 Million
Q3 2020 Nov 13, 2020	SELL	$127.12 - $172.34 $116,950 - $158,552	-920 Reduced 7.05%	12,131 $1.71 Million
Q2 2020 Aug 13, 2020	SELL	$93.0 - $171.7 $191,859 - $354,217	-2,063 Reduced 13.65%	13,051 $2.09 Million
Q1 2020 May 15, 2020	BUY	$82.38 - $131.64 $1.25 Million - $1.99 Million	15,114 New	15,114 $1.48 Million
Q4 2019 Feb 14, 2020	SELL	$76.53 - $135.58 $1.17 Million - $2.06 Million	-15,223 Closed	0 $0
Q3 2019 Nov 14, 2019	SELL	$72.81 - $156.91 $29,124 - $62,764	-400 Reduced 2.56%	15,223 $1.15 Million
Q2 2019 Aug 13, 2019	BUY	$112.21 - $151.95 $72,151 - $97,703	643 Added 4.29%	15,623 $2.37 Million
Q1 2019 May 14, 2019	BUY	$106.67 - $151.68 $30,720 - $43,683	288 Added 1.96%	14,980 $1.79 Million
Q4 2018 Feb 14, 2019	SELL	$97.32 - $148.76 $538,666 - $823,386	-5,535 Reduced 27.36%	14,692 $1.6 Million
Q3 2018 Nov 14, 2018	SELL	$115.31 - $161.51 $10,377 - $14,535	-90 Reduced 0.44%	20,227 $3.27 Million
Q2 2018 Aug 14, 2018	SELL	$71.74 - $153.69 $415,661 - $890,479	-5,794 Reduced 22.19%	20,317 $2.69 Million
Q1 2018 May 15, 2018	SELL	$54.02 - $82.27 $540 - $822	-10 Reduced 0.04%	26,111 $1.94 Million
Q4 2017 Feb 13, 2018	BUY	$47.64 - $56.75 $30,966 - $36,887	650 Added 2.55%	26,121 $1.48 Million
Q3 2017 Nov 14, 2017	BUY	$35.73 - $47.15 $464 - $612	13 Added 0.05%	25,471 $1.16 Million
Q2 2017 Aug 14, 2017	BUY	N/A	25,458	25,458 $858,000

Others Institutions Holding SRPT

# of Institutions

529

Shares Held

84.2M

Call Options Held

2.06M

Put Options Held

1.52M

Black Rock Inc. New York, NY

10.3M
Shares

$1.23 Billion
0.04% of portfolio
Vanguard Group Inc Valley Forge, PA

8.97M
Shares

$1.07 Billion
0.02% of portfolio
Capital International Investors Los Angeles, CA

6.26M
Shares

$745 Million
0.16% of portfolio
Janus Henderson Group PLC London, X0

4.36M
Shares

$519 Million
0.29% of portfolio
State Street Corp Boston, MA

4.27M
Shares

$508 Million
0.02% of portfolio

View Full List

About Sarepta Therapeutics, Inc.

Ticker SRPT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 87,567,904
Market Cap $10.4B
Description
Sarepta Therapeutics, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery and development of RNA-targeted therapeutics, gene therapies, and other genetic therapeutic modalities for the treatment of rare diseases. It offers EXONDYS 51 injection to treat duchenne muscular dystrophy (duchenne) in patients with confirmed mut...

More about SRPT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of United Capital Financial Advisers, LLC, based on Form 13F filings with the SEC.

News

Stay updated on United Capital Financial Advisers, LLC with notifications on news.

Account